Evaluation of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis: A Single Center Experience
- PMID: 35936656
- PMCID: PMC9348923
- DOI: 10.1155/2022/1784529
Evaluation of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis: A Single Center Experience
Abstract
Objectives: Macrophage activation syndrome (MAS) is a severe complication of systemic juvenile arthritis (sJIA), and early diagnosis is critical for survival. The objective of this study was to evaluate the 2016 MAS classification criteria in a Danish sJIA cohort and to compare different sets of criteria for the early identification of MAS including the HLH-2004 diagnostic guidelines, MS score, and the ferritin/ESR ratio.
Methods: Data was extracted from medical charts of 32 patients with sJIA from a single Danish paediatric rheumatology center diagnosed between January 2014 and June 2021. Patients who met the 2016 MAS classification criteria were classified as having MAS. From a receiver operating characteristic (ROC) plot, the area under the curve (AUC) was calculated for the prediction of patients with MAS according to the 2016 MAS classification criteria using either MS score or the ferritin/ESR ratio.
Results: Of the cohort, eight (25%) patients were classified as having MAS according to the 2016 MAS classification criteria compared to only three (9.4%) patients fulfilling the HLH-2004 diagnostic guidelines, all of which had recurrent MAS. The ferritin/ESR ratio showed the highest sensitivity (100%) but the lowest specificity (72.2%). In comparison, the MS score had a higher specificity (90.9%) for the identification of MAS according to the 2016 classification criteria. In our cohort, the most optimal cut-off point for the ferritin/ESR ratio was ≥19.4 (sensitivity: 100%, specificity: 72.2%) and ≥ -1.5 for the MS score (sensitivity: 71.4%, specificity: 91.7%), respectively.
Conclusion: The 2016 MAS classification criteria were a valuable tool in the discrimination of sJIA with and without MAS. The HLH-2004 diagnostic guidelines showed the lowest sensitivity, ferritin/ESR ratio, and the lowest specificity compared to the MS score where an acceptable high sensitivity and specificity was found.
Copyright © 2022 Pia Elkjær Høeg et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures

Similar articles
-
Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis.ACR Open Rheumatol. 2019 Jul 13;1(6):345-349. doi: 10.1002/acr2.11048. eCollection 2019 Aug. ACR Open Rheumatol. 2019. PMID: 31777812 Free PMC article.
-
Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.World J Pediatr. 2020 Feb;16(1):89-98. doi: 10.1007/s12519-019-00256-0. Epub 2019 Oct 14. World J Pediatr. 2020. PMID: 31612427
-
Performances of the "MS-score" And "HScore" in the diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis patients.Rheumatol Int. 2021 Jan;41(1):87-93. doi: 10.1007/s00296-020-04750-x. Epub 2020 Nov 19. Rheumatol Int. 2021. PMID: 33215249
-
Clinical variability of the systemic juvenile idiopathic arthritis course: literature review based on case series.Reumatologia. 2020;58(6):436-443. doi: 10.5114/reum.2020.102010. Epub 2020 Dec 23. Reumatologia. 2020. PMID: 33456087 Free PMC article. Review.
-
Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus: A Systematic Review of the Diagnostic Aspects.Front Med (Lausanne). 2021 Jun 4;8:681875. doi: 10.3389/fmed.2021.681875. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34150813 Free PMC article.
Cited by
-
Systemic juvenile idiopathic arthritis: frequency and long-term outcome in Western Australia.Rheumatol Int. 2023 Jul;43(7):1357-1362. doi: 10.1007/s00296-023-05318-1. Epub 2023 Mar 29. Rheumatol Int. 2023. PMID: 36988674 Free PMC article.
-
Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID Era.Int J Mol Sci. 2022 Oct 22;23(21):12757. doi: 10.3390/ijms232112757. Int J Mol Sci. 2022. PMID: 36361547 Free PMC article. Review.
References
-
- Kostik M. M., Dubko M. F., Masalova V. V., et al. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis. Seminars in Arthritis and Rheumatism. . 2015;44(4):417–422. doi: 10.1016/j.semarthrit.2014.09.004. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous